市場調査レポート

商品コード

1122863

世界の血漿タンパク質治療薬市場：考察と予測 (2028年まで)

Global Plasma Protein Therapeutics Market Insights and Forecast to 2028

出版日: 2022年09月07日 | 発行: QYResearch

| ページ情報: 英文 115 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,900 768,124円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 7,350 1,152,186円

レポートPDFを5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 9,800 1,536,248円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートは、血漿タンパク質治療薬 (Plasma Protein Therapeutics) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

血漿タンパク質治療薬の製品概要
市場：タイプ別
- 世界の血漿タンパク質治療薬の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
- Coagulation Factor
- Immune Globulin
- Albumin
- Others
市場：アプリケーション別
- 世界の血漿タンパク質治療薬の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
- Hemophilia
- PID
- Others
調査目的
対象期間

第2章レポート概要

世界の血漿タンパク質治療薬の販売推定および予測 2017-2028
世界の血漿タンパク質治療薬の収益推定および予測 2017-2028
世界の血漿タンパク質治療薬の収益：地域別: 2017 VS 2021 VS 2028
世界の血漿タンパク質治療薬の販売：地域別
- 世界の血漿タンパク質治療薬の販売：地域別 (2017-2022)
- 世界の販売血漿タンパク質治療薬：地域別 (2023-2028)
世界の血漿タンパク質治療薬の収益：地域別
- 世界の血漿タンパク質治療薬の収益：地域別 (2017-2022)
- 世界の血漿タンパク質治療薬の収益：地域別 (2023-2028)
北米
欧州
アジア太平洋地域
ラテンアメリカ
中東・アフリカ

第3章競合：メーカー別

世界の血漿タンパク質治療薬の販売：メーカー別
- 世界の血漿タンパク質治療薬の上位メーカー：販売別 (2017-2022)
- 世界の血漿タンパク質治療薬の販売市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5メーカー：血漿タンパク質治療薬2021
世界の血漿タンパク質治療薬の収益：メーカー別
- 世界の血漿タンパク質治療薬の収益：メーカー別 (2017-2022)
- 世界の血漿タンパク質治療薬の収益市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5企業：血漿タンパク質治療薬の収益 2021
世界の血漿タンパク質治療薬の販売価格：メーカー別 (2017-2022)
競合情勢の分析
- メーカーの市場集中度 (CR5 and HHI)
- 世界の血漿タンパク質治療薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
- 世界の血漿タンパク質治療薬のメーカーの地理的分布
M&A, 拡張計画

第4章市場規模：タイプ別

世界の血漿タンパク質治療薬の販売：タイプ別
- 世界の血漿タンパク質治療薬の販売実績：タイプ別 (2017-2022)
- 世界の血漿タンパク質治療薬の販売予測：タイプ別 (2023-2028)
- 世界の血漿タンパク質治療薬の販売市場シェア：タイプ別 (2017-2028)
世界の血漿タンパク質治療薬の収益：タイプ別
- 世界の血漿タンパク質治療薬の収益実績：タイプ別 (2017-2022)
- 世界の血漿タンパク質治療薬の収益予測：タイプ別 (2023-2028)
- 世界の血漿タンパク質治療薬の収益市場シェア：タイプ別 (2017-2028)
世界の血漿タンパク質治療薬の価格：タイプ別
- 世界の血漿タンパク質治療薬の価格：タイプ別 (2017-2022)
- 世界の血漿タンパク質治療薬の価格予測：タイプ別 (2023-2028)

第5章市場規模：アプリケーション別

世界の血漿タンパク質治療薬の販売：アプリケーション別
- 世界の血漿タンパク質治療薬の販売実績：アプリケーション別 (2017-2022)
- 世界の血漿タンパク質治療薬の販売予測：アプリケーション別 (2023-2028)
- 世界の血漿タンパク質治療薬の販売市場シェア：アプリケーション別 (2017-2028)
世界の血漿タンパク質治療薬の収益：アプリケーション別
- 世界の血漿タンパク質治療薬の収益実績：アプリケーション別 (2017-2022)
- 世界の血漿タンパク質治療薬の収益予測：アプリケーション別 (2023-2028)
- 世界の血漿タンパク質治療薬の収益市場シェア：アプリケーション別 (2017-2028)
世界の血漿タンパク質治療薬の価格：アプリケーション別
- 世界の血漿タンパク質治療薬の価格：アプリケーション別 (2017-2022)
- 世界の血漿タンパク質治療薬の価格予測：アプリケーション別 (2023-2028)

第6章北米

北米の血漿タンパク質治療薬市場規模：タイプ別
- 北米の血漿タンパク質治療薬の販売：タイプ別 (2017-2028)
- 北米の血漿タンパク質治療薬の収益：タイプ別 (2017-2028)
北米の血漿タンパク質治療薬市場規模：アプリケーション別
- 北米の血漿タンパク質治療薬の販売：アプリケーション別 (2017-2028)
- 北米の血漿タンパク質治療薬の収益：アプリケーション別 (2017-2028)
北米の血漿タンパク質治療薬市場規模：国別
- 北米の血漿タンパク質治療薬の販売：国別 (2017-2028)
- 北米の血漿タンパク質治療薬の収益：国別 (2017-2028)
- 米国
- カナダ

第7章欧州

欧州の血漿タンパク質治療薬市場規模：タイプ別
- 欧州の血漿タンパク質治療薬の販売：タイプ別 (2017-2028)
- 欧州の血漿タンパク質治療薬の収益：タイプ別 (2017-2028)
欧州の血漿タンパク質治療薬市場規模：アプリケーション別
- 欧州の血漿タンパク質治療薬の販売：アプリケーション別 (2017-2028)
- 欧州の血漿タンパク質治療薬の収益：アプリケーション別 (2017-2028)
欧州の血漿タンパク質治療薬市場規模：国別
- 欧州の血漿タンパク質治療薬の販売：国別 (2017-2028)
- 欧州の血漿タンパク質治療薬の収益：国別 (2017-2028)
- ドイツ
- フランス
- 英国
- イタリア
- ロシア

第8章アジア太平洋

アジア太平洋の血漿タンパク質治療薬市場規模：タイプ別
- アジア太平洋の血漿タンパク質治療薬の販売：タイプ別 (2017-2028)
- アジア太平洋の血漿タンパク質治療薬の収益：タイプ別 (2017-2028)
アジア太平洋の血漿タンパク質治療薬市場規模：アプリケーション別
- アジア太平洋の血漿タンパク質治療薬の販売：アプリケーション別 (2017-2028)
- アジア太平洋の血漿タンパク質治療薬の収益：アプリケーション別 (2017-2028)
アジア太平洋の血漿タンパク質治療薬市場規模：地域別
- アジア太平洋の血漿タンパク質治療薬の販売：地域別 (2017-2028)
- アジア太平洋の血漿タンパク質治療薬の収益：地域別 (2017-2028)
- 中国
- 日本
- 韓国
- インド
- オーストラリア
- 台湾
- インドネシア
- タイ
- マレーシア
- フィリピン

第9章ラテンアメリカ

ラテンアメリカの血漿タンパク質治療薬市場規模：タイプ別
- ラテンアメリカの血漿タンパク質治療薬の販売：タイプ別 (2017-2028)
- ラテンアメリカの血漿タンパク質治療薬の収益：タイプ別 (2017-2028)
ラテンアメリカの血漿タンパク質治療薬市場規模：アプリケーション別
- ラテンアメリカの血漿タンパク質治療薬の販売：アプリケーション別 (2017-2028)
- ラテンアメリカの血漿タンパク質治療薬の収益：アプリケーション別 (2017-2028)
ラテンアメリカの血漿タンパク質治療薬市場規模：国別
- ラテンアメリカの血漿タンパク質治療薬の販売：国別 (2017-2028)
- ラテンアメリカの血漿タンパク質治療薬の収益：国別 (2017-2028)
- メキシコ
- ブラジル
- アルゼンチン

第10章中東・アフリカ

中東・アフリカの血漿タンパク質治療薬市場規模：タイプ別
- 中東・アフリカの血漿タンパク質治療薬の販売：タイプ別 (2017-2028)
- 中東・アフリカの血漿タンパク質治療薬の収益：タイプ別 (2017-2028)
中東・アフリカの血漿タンパク質治療薬市場規模：アプリケーション別
- 中東・アフリカの血漿タンパク質治療薬の販売：アプリケーション別 (2017-2028)
- 中東・アフリカの血漿タンパク質治療薬の収益：アプリケーション別 (2017-2028)
中東・アフリカの血漿タンパク質治療薬市場規模：国別
- 中東・アフリカの血漿タンパク質治療薬の販売：国別 (2017-2028)
- 中東・アフリカの血漿タンパク質治療薬の収益：国別 (2017-2028)
- トルコ
- サウジアラビア

第11章企業プロファイル

Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada

第12章業界チェーンと販売チャネルの分析

血漿タンパク質治療薬業界チェーン分析
血漿タンパク質治療薬主要原材料分析
- 主要原材料分析
- 原材料の主要サプライヤー
血漿タンパク質治療薬生産形態とプロセス
血漿タンパク質治療薬販売およびマーケティング
- 血漿タンパク質治療薬販売チャネル
- 血漿タンパク質治療薬卸業者
血漿タンパク質治療薬顧客

第13章市場の促進要因, 機会, 課題とリスク要因の分析

血漿タンパク質治療薬業界動向
血漿タンパク質治療薬市場の促進要因
血漿タンパク質治療薬市場の課題
血漿タンパク質治療薬市場の抑制要因

第14章世界の血漿タンパク質治療薬の主な市場調査結果

第15章付録

図表

Table 1. Global Plasma Protein Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Coagulation Factor
Table 3. Major Manufacturers of Immune Globulin
Table 4. Major Manufacturers of Albumin
Table 5. Major Manufacturers of Others
Table 6. Global Plasma Protein Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Plasma Protein Therapeutics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Plasma Protein Therapeutics Sales by Region (2017-2022) & (K Units)
Table 9. Global Plasma Protein Therapeutics Sales Market Share by Region (2017-2022)
Table 10. Global Plasma Protein Therapeutics Sales by Region (2023-2028) & (K Units)
Table 11. Global Plasma Protein Therapeutics Sales Market Share by Region (2023-2028)
Table 12. Global Plasma Protein Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Plasma Protein Therapeutics Revenue Market Share by Region (2017-2022)
Table 14. Global Plasma Protein Therapeutics Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Plasma Protein Therapeutics Revenue Market Share by Region (2023-2028)
Table 16. Global Plasma Protein Therapeutics Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Plasma Protein Therapeutics Sales Share by Manufacturers (2017-2022)
Table 18. Global Plasma Protein Therapeutics Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Plasma Protein Therapeutics Revenue Share by Manufacturers (2017-2022)
Table 20. Plasma Protein Therapeutics Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Plasma Protein Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Plasma Protein Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protein Therapeutics as of 2021)
Table 23. Plasma Protein Therapeutics Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Plasma Protein Therapeutics Product Offered
Table 25. Date of Manufacturers Enter into Plasma Protein Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
Table 28. Global Plasma Protein Therapeutics Sales by Type (2023-2028) & (K Units)
Table 29. Global Plasma Protein Therapeutics Sales Share by Type (2017-2022)
Table 30. Global Plasma Protein Therapeutics Sales Share by Type (2023-2028)
Table 31. Global Plasma Protein Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Plasma Protein Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Plasma Protein Therapeutics Revenue Share by Type (2017-2022)
Table 34. Global Plasma Protein Therapeutics Revenue Share by Type (2023-2028)
Table 35. Plasma Protein Therapeutics Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Plasma Protein Therapeutics Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
Table 38. Global Plasma Protein Therapeutics Sales by Application (2023-2028) & (K Units)
Table 39. Global Plasma Protein Therapeutics Sales Share by Application (2017-2022)
Table 40. Global Plasma Protein Therapeutics Sales Share by Application (2023-2028)
Table 41. Global Plasma Protein Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Plasma Protein Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Plasma Protein Therapeutics Revenue Share by Application (2017-2022)
Table 44. Global Plasma Protein Therapeutics Revenue Share by Application (2023-2028)
Table 45. Plasma Protein Therapeutics Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Plasma Protein Therapeutics Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
Table 48. North America Plasma Protein Therapeutics Sales by Type (2023-2028) & (K Units)
Table 49. North America Plasma Protein Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Plasma Protein Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
Table 52. North America Plasma Protein Therapeutics Sales by Application (2023-2028) & (K Units)
Table 53. North America Plasma Protein Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Plasma Protein Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)
Table 56. North America Plasma Protein Therapeutics Sales by Country (2023-2028) & (K Units)
Table 57. North America Plasma Protein Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Plasma Protein Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
Table 60. Europe Plasma Protein Therapeutics Sales by Type (2023-2028) & (K Units)
Table 61. Europe Plasma Protein Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Plasma Protein Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
Table 64. Europe Plasma Protein Therapeutics Sales by Application (2023-2028) & (K Units)
Table 65. Europe Plasma Protein Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Plasma Protein Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)
Table 68. Europe Plasma Protein Therapeutics Sales by Country (2023-2028) & (K Units)
Table 69. Europe Plasma Protein Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Plasma Protein Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Plasma Protein Therapeutics Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Plasma Protein Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Plasma Protein Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Plasma Protein Therapeutics Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Plasma Protein Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Plasma Protein Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Plasma Protein Therapeutics Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Plasma Protein Therapeutics Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Plasma Protein Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Plasma Protein Therapeutics Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Plasma Protein Therapeutics Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Plasma Protein Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Plasma Protein Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Plasma Protein Therapeutics Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Plasma Protein Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Plasma Protein Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Plasma Protein Therapeutics Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Plasma Protein Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Plasma Protein Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Plasma Protein Therapeutics Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Plasma Protein Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Plasma Protein Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Plasma Protein Therapeutics Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Plasma Protein Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Plasma Protein Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Plasma Protein Therapeutics Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 107. Shire (Baxalta) Corporation Information
Table 108. Shire (Baxalta) Description and Major Businesses
Table 109. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Shire (Baxalta) Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Shire (Baxalta) Recent Developments
Table 112. CSL Corporation Information
Table 113. CSL Description and Major Businesses
Table 114. CSL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. CSL Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CSL Recent Developments
Table 117. Grifols Corporation Information
Table 118. Grifols Description and Major Businesses
Table 119. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Grifols Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Grifols Recent Developments
Table 122. Octapharma Corporation Information
Table 123. Octapharma Description and Major Businesses
Table 124. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Octapharma Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Octapharma Recent Developments
Table 127. Kedrion Corporation Information
Table 128. Kedrion Description and Major Businesses
Table 129. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Kedrion Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Kedrion Recent Developments
Table 132. LFB Group Corporation Information
Table 133. LFB Group Description and Major Businesses
Table 134. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. LFB Group Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. LFB Group Recent Developments
Table 137. Biotest Corporation Information
Table 138. Biotest Description and Major Businesses
Table 139. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Biotest Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Biotest Recent Developments
Table 142. BPL Corporation Information
Table 143. BPL Description and Major Businesses
Table 144. BPL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. BPL Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. BPL Recent Developments
Table 147. RAAS Corporation Information
Table 148. RAAS Description and Major Businesses
Table 149. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. RAAS Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. RAAS Recent Developments
Table 152. CBPO Corporation Information
Table 153. CBPO Description and Major Businesses
Table 154. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. CBPO Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. CBPO Recent Developments
Table 157. Hualan Bio Corporation Information
Table 158. Hualan Bio Description and Major Businesses
Table 159. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 160. Hualan Bio Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Hualan Bio Recent Developments
Table 162. Kamada Corporation Information
Table 163. Kamada Description and Major Businesses
Table 164. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 165. Kamada Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Kamada Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Plasma Protein Therapeutics Distributors List
Table 170. Plasma Protein Therapeutics Customers List
Table 171. Plasma Protein Therapeutics Market Trends
Table 172. Plasma Protein Therapeutics Market Drivers
Table 173. Plasma Protein Therapeutics Market Challenges
Table 174. Plasma Protein Therapeutics Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources

List of Figures

Figure 1. Plasma Protein Therapeutics Product Picture
Figure 3. Global Plasma Protein Therapeutics Market Share by Type in 2021 & 2028
Figure 3. Coagulation Factor Product Picture
Figure 4. Immune Globulin Product Picture
Figure 5. Albumin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Plasma Protein Therapeutics Market Share by Application in 2021 & 2028
Figure 8. Hemophilia
Figure 9. PID
Figure 10. Others
Figure 11. Plasma Protein Therapeutics Report Years Considered
Figure 12. Global Plasma Protein Therapeutics Sales 2017-2028 (K Units)
Figure 13. Global Plasma Protein Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Plasma Protein Therapeutics Revenue 2017-2028 (US$ Million)
Figure 15. Global Plasma Protein Therapeutics Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Plasma Protein Therapeutics Sales Market Share by Region (2017-2022)
Figure 17. Global Plasma Protein Therapeutics Sales Market Share by Region (2023-2028)
Figure 18. North America Plasma Protein Therapeutics Sales YoY (2017-2028) & (K Units)
Figure 19. North America Plasma Protein Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Plasma Protein Therapeutics Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Plasma Protein Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Plasma Protein Therapeutics Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Plasma Protein Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Plasma Protein Therapeutics Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Plasma Protein Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Plasma Protein Therapeutics Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Plasma Protein Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Plasma Protein Therapeutics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Plasma Protein Therapeutics in the World: Market Share by Plasma Protein Therapeutics Revenue in 2021
Figure 30. Global Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
Figure 32. Global Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
Figure 33. Global Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
Figure 34. Global Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
Figure 35. North America Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
Figure 36. North America Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
Figure 37. North America Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
Figure 38. North America Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
Figure 39. North America Plasma Protein Therapeutics Sales Share by Country (2017-2028)
Figure 40. North America Plasma Protein Therapeutics Revenue Share by Country (2017-2028)
Figure 41. U.S. Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
Figure 44. Europe Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
Figure 45. Europe Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
Figure 46. Europe Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
Figure 47. Europe Plasma Protein Therapeutics Sales Share by Country (2017-2028)
Figure 48. Europe Plasma Protein Therapeutics Revenue Share by Country (2017-2028)
Figure 49. Germany Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 50. France Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Plasma Protein Therapeutics Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Plasma Protein Therapeutics Revenue Share by Region (2017-2028)
Figure 60. China Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 63. India Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
Figure 71. Latin America Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
Figure 73. Latin America Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Plasma Protein Therapeutics Sales Share by Country (2017-2028)
Figure 75. Latin America Plasma Protein Therapeutics Revenue Share by Country (2017-2028)
Figure 76. Mexico Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Plasma Protein Therapeutics Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Plasma Protein Therapeutics Revenue Share by Country (2017-2028)
Figure 85. Turkey Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 87. U.A.E Plasma Protein Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 88. Plasma Protein Therapeutics Value Chain
Figure 89. Plasma Protein Therapeutics Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

This research report focuses on the Plasma Protein Therapeutics Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

1 Study Coverage

1.1 Plasma Protein Therapeutics Product Introduction
1.2 Market by Type
- 1.2.1 Global Plasma Protein Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Coagulation Factor
- 1.2.3 Immune Globulin
- 1.2.4 Albumin
- 1.2.5 Others
1.3 Market by Application
- 1.3.1 Global Plasma Protein Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Hemophilia
- 1.3.3 PID
- 1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary

2.1 Global Plasma Protein Therapeutics Sales Estimates and Forecasts 2017-2028
2.2 Global Plasma Protein Therapeutics Revenue Estimates and Forecasts 2017-2028
2.3 Global Plasma Protein Therapeutics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Plasma Protein Therapeutics Sales by Region
- 2.4.1 Global Plasma Protein Therapeutics Sales by Region (2017-2022)
- 2.4.2 Global Sales Plasma Protein Therapeutics by Region (2023-2028)
2.5 Global Plasma Protein Therapeutics Revenue by Region
- 2.5.1 Global Plasma Protein Therapeutics Revenue by Region (2017-2022)
- 2.5.2 Global Plasma Protein Therapeutics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Plasma Protein Therapeutics Sales by Manufacturers
- 3.1.1 Global Top Plasma Protein Therapeutics Manufacturers by Sales (2017-2022)
- 3.1.2 Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2017-2022)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Plasma Protein Therapeutics in 2021
3.2 Global Plasma Protein Therapeutics Revenue by Manufacturers
- 3.2.1 Global Plasma Protein Therapeutics Revenue by Manufacturers (2017-2022)
- 3.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2017-2022)
- 3.2.3 Global Top 10 and Top 5 Companies by Plasma Protein Therapeutics Revenue in 2021
3.3 Global Plasma Protein Therapeutics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Plasma Protein Therapeutics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Plasma Protein Therapeutics Sales by Type
- 4.1.1 Global Plasma Protein Therapeutics Historical Sales by Type (2017-2022)
- 4.1.2 Global Plasma Protein Therapeutics Forecasted Sales by Type (2023-2028)
- 4.1.3 Global Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
4.2 Global Plasma Protein Therapeutics Revenue by Type
- 4.2.1 Global Plasma Protein Therapeutics Historical Revenue by Type (2017-2022)
- 4.2.2 Global Plasma Protein Therapeutics Forecasted Revenue by Type (2023-2028)
- 4.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
4.3 Global Plasma Protein Therapeutics Price by Type
- 4.3.1 Global Plasma Protein Therapeutics Price by Type (2017-2022)
- 4.3.2 Global Plasma Protein Therapeutics Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Plasma Protein Therapeutics Sales by Application
- 5.1.1 Global Plasma Protein Therapeutics Historical Sales by Application (2017-2022)
- 5.1.2 Global Plasma Protein Therapeutics Forecasted Sales by Application (2023-2028)
- 5.1.3 Global Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
5.2 Global Plasma Protein Therapeutics Revenue by Application
- 5.2.1 Global Plasma Protein Therapeutics Historical Revenue by Application (2017-2022)
- 5.2.2 Global Plasma Protein Therapeutics Forecasted Revenue by Application (2023-2028)
- 5.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
5.3 Global Plasma Protein Therapeutics Price by Application
- 5.3.1 Global Plasma Protein Therapeutics Price by Application (2017-2022)
- 5.3.2 Global Plasma Protein Therapeutics Price Forecast by Application (2023-2028)

6 North America

6.1 North America Plasma Protein Therapeutics Market Size by Type
- 6.1.1 North America Plasma Protein Therapeutics Sales by Type (2017-2028)
- 6.1.2 North America Plasma Protein Therapeutics Revenue by Type (2017-2028)
6.2 North America Plasma Protein Therapeutics Market Size by Application
- 6.2.1 North America Plasma Protein Therapeutics Sales by Application (2017-2028)
- 6.2.2 North America Plasma Protein Therapeutics Revenue by Application (2017-2028)
6.3 North America Plasma Protein Therapeutics Market Size by Country
- 6.3.1 North America Plasma Protein Therapeutics Sales by Country (2017-2028)
- 6.3.2 North America Plasma Protein Therapeutics Revenue by Country (2017-2028)
- 6.3.3 U.S.
- 6.3.4 Canada

7 Europe

7.1 Europe Plasma Protein Therapeutics Market Size by Type
- 7.1.1 Europe Plasma Protein Therapeutics Sales by Type (2017-2028)
- 7.1.2 Europe Plasma Protein Therapeutics Revenue by Type (2017-2028)
7.2 Europe Plasma Protein Therapeutics Market Size by Application
- 7.2.1 Europe Plasma Protein Therapeutics Sales by Application (2017-2028)
- 7.2.2 Europe Plasma Protein Therapeutics Revenue by Application (2017-2028)
7.3 Europe Plasma Protein Therapeutics Market Size by Country
- 7.3.1 Europe Plasma Protein Therapeutics Sales by Country (2017-2028)
- 7.3.2 Europe Plasma Protein Therapeutics Revenue by Country (2017-2028)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Plasma Protein Therapeutics Market Size by Type
- 8.1.1 Asia Pacific Plasma Protein Therapeutics Sales by Type (2017-2028)
- 8.1.2 Asia Pacific Plasma Protein Therapeutics Revenue by Type (2017-2028)
8.2 Asia Pacific Plasma Protein Therapeutics Market Size by Application
- 8.2.1 Asia Pacific Plasma Protein Therapeutics Sales by Application (2017-2028)
- 8.2.2 Asia Pacific Plasma Protein Therapeutics Revenue by Application (2017-2028)
8.3 Asia Pacific Plasma Protein Therapeutics Market Size by Region
- 8.3.1 Asia Pacific Plasma Protein Therapeutics Sales by Region (2017-2028)
- 8.3.2 Asia Pacific Plasma Protein Therapeutics Revenue by Region (2017-2028)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 Taiwan
- 8.3.9 Indonesia
- 8.3.10 Thailand
- 8.3.11 Malaysia
- 8.3.12 Philippines

9 Latin America

9.1 Latin America Plasma Protein Therapeutics Market Size by Type
- 9.1.1 Latin America Plasma Protein Therapeutics Sales by Type (2017-2028)
- 9.1.2 Latin America Plasma Protein Therapeutics Revenue by Type (2017-2028)
9.2 Latin America Plasma Protein Therapeutics Market Size by Application
- 9.2.1 Latin America Plasma Protein Therapeutics Sales by Application (2017-2028)
- 9.2.2 Latin America Plasma Protein Therapeutics Revenue by Application (2017-2028)
9.3 Latin America Plasma Protein Therapeutics Market Size by Country
- 9.3.1 Latin America Plasma Protein Therapeutics Sales by Country (2017-2028)
- 9.3.2 Latin America Plasma Protein Therapeutics Revenue by Country (2017-2028)
- 9.3.3 Mexico
- 9.3.4 Brazil
- 9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Plasma Protein Therapeutics Market Size by Type
- 10.1.1 Middle East and Africa Plasma Protein Therapeutics Sales by Type (2017-2028)
- 10.1.2 Middle East and Africa Plasma Protein Therapeutics Revenue by Type (2017-2028)
10.2 Middle East and Africa Plasma Protein Therapeutics Market Size by Application
- 10.2.1 Middle East and Africa Plasma Protein Therapeutics Sales by Application (2017-2028)
- 10.2.2 Middle East and Africa Plasma Protein Therapeutics Revenue by Application (2017-2028)
10.3 Middle East and Africa Plasma Protein Therapeutics Market Size by Country
- 10.3.1 Middle East and Africa Plasma Protein Therapeutics Sales by Country (2017-2028)
- 10.3.2 Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2017-2028)
- 10.3.3 Turkey
- 10.3.4 Saudi Arabia

11 Company Profiles

11.1 Shire (Baxalta)
- 11.1.1 Shire (Baxalta) Corporation Information
- 11.1.2 Shire (Baxalta) Overview
- 11.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.1.4 Shire (Baxalta) Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 Shire (Baxalta) Recent Developments
11.2 CSL
- 11.2.1 CSL Corporation Information
- 11.2.2 CSL Overview
- 11.2.3 CSL Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.2.4 CSL Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 CSL Recent Developments
11.3 Grifols
- 11.3.1 Grifols Corporation Information
- 11.3.2 Grifols Overview
- 11.3.3 Grifols Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.3.4 Grifols Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
- 11.3.5 Grifols Recent Developments
11.4 Octapharma
- 11.4.1 Octapharma Corporation Information
- 11.4.2 Octapharma Overview
- 11.4.3 Octapharma Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.4.4 Octapharma Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
- 11.4.5 Octapharma Recent Developments
11.5 Kedrion
- 11.5.1 Kedrion Corporation Information
- 11.5.2 Kedrion Overview
- 11.5.3 Kedrion Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.5.4 Kedrion Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
- 11.5.5 Kedrion Recent Developments
11.6 LFB Group
- 11.6.1 LFB Group Corporation Information
- 11.6.2 LFB Group Overview
- 11.6.3 LFB Group Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.6.4 LFB Group Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
- 11.6.5 LFB Group Recent Developments
11.7 Biotest
- 11.7.1 Biotest Corporation Information
- 11.7.2 Biotest Overview
- 11.7.3 Biotest Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.7.4 Biotest Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
- 11.7.5 Biotest Recent Developments
11.8 BPL
- 11.8.1 BPL Corporation Information
- 11.8.2 BPL Overview
- 11.8.3 BPL Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.8.4 BPL Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
- 11.8.5 BPL Recent Developments
11.9 RAAS
- 11.9.1 RAAS Corporation Information
- 11.9.2 RAAS Overview
- 11.9.3 RAAS Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.9.4 RAAS Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
- 11.9.5 RAAS Recent Developments
11.10 CBPO
- 11.10.1 CBPO Corporation Information
- 11.10.2 CBPO Overview
- 11.10.3 CBPO Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.10.4 CBPO Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
- 11.10.5 CBPO Recent Developments
11.11 Hualan Bio
- 11.11.1 Hualan Bio Corporation Information
- 11.11.2 Hualan Bio Overview
- 11.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.11.4 Hualan Bio Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
- 11.11.5 Hualan Bio Recent Developments
11.12 Kamada
- 11.12.1 Kamada Corporation Information
- 11.12.2 Kamada Overview
- 11.12.3 Kamada Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.12.4 Kamada Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
- 11.12.5 Kamada Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Plasma Protein Therapeutics Industry Chain Analysis
12.2 Plasma Protein Therapeutics Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
12.3 Plasma Protein Therapeutics Production Mode & Process
12.4 Plasma Protein Therapeutics Sales and Marketing
- 12.4.1 Plasma Protein Therapeutics Sales Channels
- 12.4.2 Plasma Protein Therapeutics Distributors
12.5 Plasma Protein Therapeutics Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Plasma Protein Therapeutics Industry Trends
13.2 Plasma Protein Therapeutics Market Drivers
13.3 Plasma Protein Therapeutics Market Challenges
13.4 Plasma Protein Therapeutics Market Restraints

14 Key Findings in The Global Plasma Protein Therapeutics Study

15 Appendix

15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

世界の血漿タンパク質治療薬市場：考察と予測 (2028年まで)

Global Plasma Protein Therapeutics Market Insights and Forecast to 2028

目次

第1章調査対象

第2章レポート概要

第3章競合：メーカー別

第4章市場規模：タイプ別

第5章市場規模：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋

第9章ラテンアメリカ

第10章中東・アフリカ

第11章企業プロファイル

第12章業界チェーンと販売チャネルの分析

第13章市場の促進要因, 機会, 課題とリスク要因の分析

第14章世界の血漿タンパク質治療薬の主な市場調査結果

第15章付録

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Executive Summary

3 Competition by Manufacturers

4 Market Size by Type

5 Market Size by Application

6 North America

7 Europe

8 Asia Pacific

9 Latin America

10 Middle East and Africa

11 Company Profiles

12 Industry Chain and Sales Channels Analysis

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14 Key Findings in The Global Plasma Protein Therapeutics Study

15 Appendix

世界の血漿タンパク質治療薬市場：考察と予測 (2028年まで)

Global Plasma Protein Therapeutics Market Insights and Forecast to 2028

目次

第1章 調査対象

第2章 レポート概要

第3章 競合：メーカー別

第4章 市場規模：タイプ別

第5章 市場規模：アプリケーション別

第6章 北米

第7章 欧州

第8章 アジア太平洋

第9章 ラテンアメリカ

第10章 中東・アフリカ

第11章 企業プロファイル

第12章 業界チェーンと販売チャネルの分析

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

第14章 世界の血漿タンパク質治療薬の主な市場調査結果

第15章 付録

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Executive Summary

3 Competition by Manufacturers

4 Market Size by Type

5 Market Size by Application

6 North America

7 Europe

8 Asia Pacific

9 Latin America

10 Middle East and Africa

11 Company Profiles

12 Industry Chain and Sales Channels Analysis

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14 Key Findings in The Global Plasma Protein Therapeutics Study

15 Appendix

第1章調査対象

第2章レポート概要

第3章競合：メーカー別

第4章市場規模：タイプ別

第5章市場規模：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋

第9章ラテンアメリカ

第10章中東・アフリカ

第11章企業プロファイル

第12章業界チェーンと販売チャネルの分析

第13章市場の促進要因, 機会, 課題とリスク要因の分析

第14章世界の血漿タンパク質治療薬の主な市場調査結果

第15章付録